Rapid Fire Poster

127 - Rapid Fire Poster Session: HIV

Presentations:

• 12:15 PM - 12:20 PM

  984 - Perceptions of and Preferences for Oral or Long-Acting Injectable Antiretroviral Treatment Regimens in the United States and Canada
  Cindy Garris, MSPH – ViiV Healthcare; Sebastian Heidenreich, PhD – Evidera; Erin Arthurs, MSc – GSK; Frank Spinelli, MD – ViiV Healthcare; Katelyn Cutts, MS – Evidera; Erik S. Lowman, DO – Midland Medical Center; Howard L. Rice, MD; Bertrand Lebouche, MD PhD – McGill University; Hannah Collacott, MSc – Evidera; Gin Nie Chua, PhD – Evidera; Heather Gelhorn, PhD – Evidera
• 12:20 PM - 12:25 PM

  983 - Association of Structural Stigma Due to Sexual Orientation and HIV Diagnosis/PrEP Use in the United States: An Ecological Analysis
  Nguyen K. Tran, MPH – Drexel University Dornsife School of Public Health; Neal Goldstein, PhD, MBI – Drexel University Dornsife School of Public Health
• 12:25 PM - 12:30 PM

  981 - Exploring the Prevalence and Characteristics of Weight Gain and other Metabolic Changes in Patients with HIV Infection Switching to Integrase Inhibitor Containing ART
  Matty Zimmerman – Jefferson College of Pharmacy; Joseph DeSimone, MD – Sidney Kimmel Medical College at Thomas Jefferson University; Jason J. Schafer, PharmD, MPH – Jefferson College of Pharmacy
• 12:30 PM - 12:35 PM

  986 - Inpatient Initiation of ART Improves Short Term Mortality in People Living with HIV
  Jamie Campbell, DO – Atrium Health; Christopher Polk, MD – Atrium Health; Danya Roshdy, PharmD, BCPS, BCIDP – Atrium Health; Michael Leonard, MD – Atrium Health
• 12:35 PM - 12:40 PM

  985 - Trans Females Receiving Gender-Affirming Surgical Referrals are More Likely to Have Durable Virologic Suppression at Whitman-Walker Health, 2008-2017
  Deborah Goldstein, MD – Whitman-Walker Institute; Eleanor Sarkodie, MPH – Whitman-Walker Institute; W. David Hardy, MD, AAHIVS – Division of Infectious Diseases, Johns Hopkins University School of Medicine

Co-Author(s)

• JD

  Joseph DeSimone, MD

  Professor of Medicine
  Sidney Kimmel Medical College at Thomas Jefferson University
  Philadelphia, PA

  Disclosure: Nothing to disclose
• NG

  Neal Goldstein, PhD, MBI

  Epidemiologist
  Drexel University Dornsife School of Public Health
  Philadelphia, PA

  Disclosure: Nothing to disclose
• SH

  Sebastian Heidenreich, PhD

  Research Scientist
  Evidera
  London, England, United Kingdom

  Disclosure: ViiV Healthcare: Consultant
• CP

  Christopher Polk, MD

  Assistant Professor
  Atrium Health
  Charlotte, North Carolina

  Disclosure: Gilead: Scientific Research Study Investigator
  Viiv Healthcare: Advisor or Review Panel member
  ViiV Healthcare: Scientific Research Study Investigator
• ES

  Eleanor Sarkodie, MPH

  Ms.
  Whitman-Walker Institute
  Washington, DC

  Disclosure: Nothing to disclose
• EA

  Erin Arthurs, MSc

  Health Outcomes Manager
  GSK
  Toronto, ON, Canada

  Disclosure: GlaxoSmithKline: Employee
• WH

  W. David Hardy, MD, AAHIVS

  Adjunct Professor of Medicine
  Division of Infectious Diseases, Johns Hopkins University School of Medicine
  Washington, DC

  Disclosure: CSL Behring (Calimmune): Consultant
  Enochian Biosciences: Consultant
  Gilead Sciences, Inc.: Advisory Board, Research Grant
  Janssen Pharm: Research Grant
  Merck: Advisory Board, Research Grant
  ViiV HealthCare Inc: Advisory Board, Consultant, Research Grant
• DR

  Danya Roshdy, PharmD, BCPS, BCIDP

  Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship
  Atrium Health
  Charlotte, NC

  Disclosure: Paratek Pharmaceuticals: Received compensation for focus group
• JS

  Jason Schafer, PharmD, MPH

  Associate Professor
  Jefferson College of Pharmacy
  Philadelphia, PA

  Disclosure: Gilead: Grant/Research Support
  Merck: Grant/Research Support
• ML

  Michael Leonard, MD

  Professor
  Atrium Health
  Charlotte, North Carolina

  Disclosure: Nothing to disclose
• FS

  Frank Spinelli, MD

  Medical Director, US Patient Affairs
  ViiV Healthcare
  Sag Harbor, NY

  Disclosure: ViiV Healthcare: Employee
• KC

  Katelyn Cutts, MS

  Research Associate
  Evidera
  Bethesda, MD

  Disclosure: Nothing to disclose
• EL

  Erik Lowman, DO

  Research Director
  Midland Medical Center
  Oakland Park, FL

  Disclosure: Nothing to disclose
• HR

  Howard Rice, MD

  Private Practice
  Mountain View, CA

  Disclosure: Nothing to disclose
• BL

  Bertrand Lebouche, MD PhD

  Assistant Professor
  McGill University
  Montreal, QC, Canada

  Disclosure: Nothing to disclose
• HC

  Hannah Collacott, MSc

  Research Associate
  Evidera
  London, England, United Kingdom

  Disclosure: ViiV Healthcare: Consultant
• GC

  Gin Nie Chua, PhD

  Research Associate
  Evidera
  London, England, United Kingdom

  Disclosure: Nothing to disclose
• HG

  Heather Gelhorn, PhD

  Senior Research Leader
  Evidera
  Bethesda, MD

  Disclosure: Nothing to disclose

Moderator(s)

• 

  Rochelle Walensky, MD, MPH

  Professor of Medicine
  Massachusetts General Hospital
  Boston, MA

Presenting Author(s)

• JC

  Jamie Campbell, DO

  Resident Physician
  Atrium Health
  Charlotte, NC

  Disclosure: Nothing to disclose
• CG

  Cindy Garris, MSPH

  Director
  ViiV Healthcare
  Chapel Hill, NC

  Disclosure: GlaxoSmithKline: Shareholder
  ViiV Healthcare: Employee
• DG

  Deborah Goldstein, MD

  Director of Clinical Research
  Whitman-Walker Institute
  Washington, DC

  Disclosure: District of Columbia Center for AIDS Research, an NIH funded program (AI117970): Grant/Research Support
• NT

  Nguyen Tran, MPH

  Ph.D. Candidate
  Drexel University Dornsife School of Public Health
  Philadelphia, PA

  Disclosure: Nothing to disclose
• MZ

  Matty Zimmerman

  Student Pharmacist
  Jefferson College of Pharmacy
  Philadelphia, PA

  Disclosure: Nothing to disclose